Stem cell therapy for athletes is a treatment that involves collecting cells — usually from the athlete’s own bone marrow or fat tissue — and injecting them into an injured area like a knee, shoulder, or tendon. The goal is to reduce pain and support tissue repair. What it does not do is rebuild cartilage, regrow a torn ligament, or replace surgery in cases where surgery is clearly needed. That gap between what the treatment aims to do and what it has actually been proven to do is the center of a real and ongoing debate in sports medicine.
What Does Stem Cell Therapy Do For Athletes?
The honest answer is that it depends on the injury, the type of cells used, and whether you are asking about pain relief or tissue regeneration. Those are two very different outcomes.
For pain relief, some evidence supports the use of certain cell-based injections. For actual tissue regrowth — rebuilding cartilage, for example — the evidence in humans is far weaker. Most of what is claimed in clinics and marketing materials goes beyond what clinical trials have demonstrated.
The most studied approach in athletes is orthobiologics, a category that includes platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and cultured stem cell injections. These are related but not identical. PRP uses concentrated platelets from your own blood. BMAC uses a mix of cells drawn from bone marrow, including some stem cells. Each has a different evidence base.
Stem cells themselves are cells that can divide and develop into different cell types. Mesenchymal stem cells (MSCs), the type most relevant to sports medicine, can become bone, cartilage, or fat cells under the right conditions in a lab. Whether they reliably do that inside a human joint after injection is a separate question — and one that researchers are still working to answer.
Which Sports Injuries Are Most Commonly Treated With Stem Cell Therapy?
Knee osteoarthritis, partial ligament tears, tendon injuries, and cartilage defects are the conditions most frequently targeted. These are also the injuries where athletes face the longest recovery times and the most uncertainty about returning to peak performance.
Specific injuries commonly discussed include:
- Partial ACL or MCL tears
- Achilles tendinopathy and other chronic tendon problems
- Patellar tendinopathy (jumper’s knee)
- Knee osteoarthritis
- Focal cartilage defects in the knee
- Rotator cuff injuries
- Hamstring and muscle strains
Not all of these have the same level of evidence behind cell-based treatment. Knee osteoarthritis and focal cartilage defects have been studied more than most others. Tendon injuries have some supporting research but less consistency across studies. Muscle strains are often treated with PRP rather than stem cells, and results there have been mixed.
One important distinction: a partial tear and a complete tear are not the same problem. Complete ACL ruptures almost always require surgical reconstruction. No injection therapy has been shown to reliably heal a fully torn ACL. That is not a gray area.
How Is Stem Cell Therapy Actually Performed?
Most procedures follow a similar sequence. Cells are harvested, sometimes processed, and then injected — usually in a single session, though some protocols involve more than one.
The most common harvesting method is a bone marrow aspirate from the back of the pelvis (the posterior iliac crest). This is done under local anesthesia. The marrow is then concentrated in a centrifuge to increase the number of nucleated cells, including MSCs. The resulting concentrate is injected into the injured area, sometimes with imaging guidance such as ultrasound.
Fat tissue (adipose) is another source. It contains MSCs as well, and harvesting typically involves a minor liposuction procedure. Adipose tissue yields more cells per volume than bone marrow, but whether that translates to better outcomes in joints is not established.
A third approach uses cultured stem cells — cells expanded in a lab over weeks before being injected. This is more common outside the United States, partly because of regulatory differences. The FDA has not approved cultured stem cell products for orthopedic use, and clinics offering them in the US operate in a regulatory gray zone.
Recovery varies. Many athletes are told to rest the treated area for a few days to a few weeks, then gradually return to activity. There is no single standard protocol, and rehabilitation timelines differ significantly between clinics.
What Does the Evidence Actually Show?
This is where the gap between marketing and medicine becomes clear. Some studies show meaningful pain reduction and functional improvement in knee osteoarthritis after MSC injections. But most of these studies are small, and many lack a placebo control group. That matters because knee osteoarthritis pain can fluctuate, and placebo effects in injection studies are well documented.
A 2020 review of the evidence on cell-based therapies for knee osteoarthritis found that while early results were encouraging, the overall quality of evidence was low to moderate. The authors noted that larger, well-controlled trials were needed before these treatments could be considered standard of care. That conclusion has not changed dramatically since.
For cartilage repair specifically, the picture is even less clear. Some studies report improvements in cartilage appearance on MRI after MSC injections, but whether those changes translate to lasting clinical benefit — less pain, better function, delayed need for surgery — is not well established.
For tendon injuries, PRP has been studied more than stem cells. Results have been inconsistent. Some trials show benefit; others show no difference compared to placebo or standard rehabilitation. The American Academy of Orthopaedic Surgeons has generally stopped short of recommending PRP as a first-line treatment for most tendon conditions, citing insufficient evidence.
What the evidence does support: cell-based injections appear to be relatively low-risk when using the patient’s own cells, with the most common side effects being temporary pain, swelling, or stiffness at the injection site. Serious complications are rare but have been reported, particularly with cultured cells or cells from donors.
Why Do Some Athletes Report Dramatic Results?
Several factors can make a treatment look more effective than it is. This is not cynicism — it is how clinical research works.
First, many athletes who receive these injections are also doing intensive physical therapy, taking time off from training, or recovering from a procedure that would have improved on its own. Attributing the recovery entirely to the injection is not scientifically sound.
Second, the placebo effect is real and measurable. In injection studies, patients who receive saline often report meaningful pain relief. This is not “in their head” — it involves actual changes in pain signaling in the nervous system.
Third, regression to the mean. Athletes typically seek treatment when their pain is at its worst. Pain often improves over time regardless of what is done, simply because the worst point has passed.
Fourth, publication and media bias. Dramatic success stories get shared. Cases where the treatment did not work — or where the athlete eventually needed surgery anyway — rarely make headlines.
None of this means the treatments do not work. It means that individual success stories are not strong evidence. Controlled trials are. And the controlled trials, so far, show modest and inconsistent benefits.
Is Stem Cell Therapy Approved for Athletes in the US?
The FDA regulates stem cell products based on how they are processed and used. Injecting a patient’s own bone marrow or fat tissue in the same surgical session — with minimal manipulation — is generally allowed. Culturing or expanding cells in a lab, or using cells from a donor, typically requires FDA approval, which most orthopedic stem cell clinics do not have.
This means that some clinics offering “stem cell therapy” in the US are operating outside the boundaries of what the FDA considers compliant. The FDA has issued warnings to clinics making unproven claims, and enforcement has increased in recent years.
For athletes, the practical implication is this: if a clinic is offering cultured or donor cells for an orthopedic injury in the US, ask what regulatory pathway they are operating under. If the answer is unclear, that is a red flag.
Outside the US, regulation varies widely. Some countries have permissive rules that allow treatments not available in the US. That does not automatically mean those treatments are safer or more effective — it often means they have not been held to the same evidentiary standard.
What Should Athletes Consider Before Trying It?
Stem cell therapy for sports injuries is not a first-line treatment. It is typically considered after conservative approaches — rest, physical therapy, activity modification — have been tried. In some cases, it is considered as an alternative to surgery, but only when surgery is not urgently required.
Questions worth asking a clinician:
- What type of cells are being used, and where do they come from?
- Is this treatment FDA-compliant for my specific situation?
- What does the evidence show for my specific injury?
- What are the alternatives, including doing nothing or standard rehab?
- What is the realistic timeline for improvement, and what happens if it does not work?
Cost is also a factor. These procedures are almost never covered by insurance in the US, and prices range from a few thousand to well over ten thousand dollars depending on the clinic and the procedure. That cost is borne entirely by the athlete.
The most important thing to understand is that “stem cell therapy” is not one treatment. It is a category that includes very different approaches with very different levels of evidence. Some are supported by early clinical research. Others are not supported by any rigorous human trials. Treating them as equivalent — which marketing often does — is misleading.
Frequently Asked Questions
Does stem cell therapy help athletes heal faster?
Some studies suggest modest pain reduction and functional improvement, particularly for knee osteoarthritis, but evidence for faster tissue healing is limited. No large controlled trial has confirmed that stem cell injections speed recovery compared to standard rehabilitation.
Can stem cell therapy regrow cartilage in the knee?
No human study has reliably demonstrated that stem cell injections regrow cartilage. Some research shows changes on MRI, but whether those changes produce lasting clinical benefit is not established.
Is stem cell therapy FDA-approved for sports injuries?
The FDA allows same-session use of a patient’s own minimally manipulated cells, but has not approved cultured or donor stem cell products for orthopedic injuries. Many US clinics offering these treatments are operating outside FDA approval.
How much does stem cell therapy cost for athletes?
Costs typically range from a few thousand to over ten thousand dollars per procedure in the US, and insurance rarely covers it. Prices vary widely by clinic and by the type of cells used.

